Health Advance Inc.
Health Advance Inc.
Your view on HADV
Overview
What the company does, where it operates, and who runs it.
About Health Advance Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Larry McLachlin
- Headquarters
- 3651 Lindell Road, Las Vegas, NV, US
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Larry McLachlin
- Headquarters
- 3651 Lindell Road, Las Vegas, NV, US
Health Advance Inc., a development stage company, operates as an on-line retailer of home medical products in Canada and the United States.
It intends to offers aids to daily living, ambulatory, bath safety, core wound care, diabetic, enteral nutrition-feeding, home diagnostics, incontinence, orthopedic, ostomy, pain management, professional use and diagnostic, respiratory, tracheostomy care, specialty wound care, and women-infant products.
The company's product portfolio would also include bed accessories, catheters, diagnostic equipment, lift chairs/geri chairs, IV supplies, needles/syringes, patient lifts and acc, personal protection products/gloves, scooters and accessories, seating/cushions, specialty medical equipment and accessories, urological/collection devices, wheelchairs accessories.
It focuses on operating leadingmedicalproducts.com, an e-commerce site for the retail community and health care community. The company intends to serve health care professionals, medical distributors, and consumers. Health Advance Inc. was founded in 2010 and is based in Las Vegas, Nevada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Health Advance Inc., and the rating behind it. HADV last traded at $0.0003; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Health Advance Inc.. Starting points for Health Advance Inc.: beta 0.53 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Health Advance Inc.. Health Advance Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Health Advance Inc.. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Health Advance Inc.. Health Advance Inc. has reported as a listed company since 2012. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Health Advance Inc. valued side by side against its closest peers. Health Advance Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Health Advance Inc., and how their positions are changing. At a $48,284 market value, institutional positions materially move Health Advance Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Health Advance Inc. executives and directors. Shares of Health Advance Inc. have traded between $0.0002 and $0.0008 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Health Advance Inc.. Health Advance Inc. is a $48,284 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Health Advance Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Health Advance Inc.. Coverage tracks Health Advance Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.